The von Willebrand factor propolypeptide, von Willebrand antigen II (vWAgII), distinguishes acquired von Willebrand syndrome (AvWS) due to decreased synthesis of von Willebrand factor (vWF) from AvWS due to increased clearance of vWF.

被引：0
|
作者：
Scott, JP
Vokac, EA
Schroeder, T
Foster, PA
Gill, JC
Montgomery, PR
机构：
[1] MED COLL WISCONSIN,DEPT PEDIAT,MILWAUKEE,WI 53226
[2] BLOOD CTR SE WISCONSIN INC,BLOOD RES INST,MILWAUKEE,WI 53233
来源：
BLOOD | 1995年 / 86卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：773 / 773
页数：1
相关论文
共 50 条
  • [41] A candidate mechanism for von Willebrand factor abnormalities in a patient with acquired von Willebrand syndrome
    Haj, MA
    Murch, N
    Bowen, DJ
    Collin, PW
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2006, 133 : 43 - 43
  • [42] Von Willebrand factor (VWF) as a risk factor for bleeding and thrombosis
    Lazzari, M. A.
    Sanchez-Luceros, A.
    Woods, A. I.
    Alberto, M. F.
    Meschengieser, S. S.
    [J]. HEMATOLOGY, 2012, 17 : S150 - S152
  • [43] Detection of non-inhibitory binding antibodies to von Willebrand factor affecting the clearance of VWF:Ag in von Willebrand disease
    Suiter, T. M.
    Mannucci, P. M.
    Kempton, C. L.
    Laffan, M.
    Romond, E. H.
    Shapiro, A. D.
    Birschmann, I.
    Ragni, M. V.
    Gill, J. C.
    Klamroth, R.
    Reipert, B. M.
    Turecek, P. L.
    Varadi, K.
    Chapman, M.
    Engl, W.
    Ewenstein, B. M.
    [J]. HAEMOPHILIA, 2012, 18 : 200 - 200
  • [44] von Willebrand factor Ristocetin co-factor activity to von Willebrand factor antigen level ratio for diagnosis of acquired von Willebrand syndrome caused by aortic stenosis
    Okubo, Noriyuki
    Sugawara, Shingo
    Fujiwara, Tohru
    Sakatsume, Ko
    Doman, Tsuyoshi
    Yamashita, Mihoko
    Goto, Kota
    Tateishi, Masaki
    Suzuki, Misako
    Shirakawa, Ryutaro
    Eura, Yuka
    Kokame, Koichi
    Hayakawa, Masaki
    Matsumoto, Masanori
    Kawate, Yasunori
    Miura, Mizuki
    Takiguchi, Hiroshi
    Soga, Yoshimitsu
    Shirai, Shinichi
    Ando, Kenji
    Arai, Yoshio
    Nakayoshi, Takaharu
    Fukumoto, Yoshihiro
    Takahama, Hiroyuki
    Yasuda, Satoshi
    Tamura, Toshihiro
    Watanabe, Shin
    Kimura, Takeshi
    Yaoita, Nobuhiro
    Shimokawa, Hiroaki
    Saiki, Yoshikatsu
    Kaikita, Koichi
    Tsujita, Kenichi
    Yoshii, Shinji
    Nakase, Hiroshi
    Fujimaki, Shin-ichi
    Horiuchi, Hisanori
    [J]. RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2024, 8 (01)
  • [45] The challenging management of a child with type 3 von Willebrand disease (VWD) and antibodies to von Willebrand factor (VWF)
    Platokouki, H.
    Pergantou, H.
    Xafaki, P.
    Adamtziki, E.
    [J]. HAEMOPHILIA, 2012, 18 : 44 - 44
  • [46] VON-WILLEBRAND DISEASE (VWD) IN THE RIIIS/J-MOUSE IS DUE TO A DEFECT OUTSIDE OF THE VON-WILLEBRAND-FACTOR (VWF) GENE
    MOHLKE, KL
    NICHOLS, WC
    COONEY, KA
    YANG, A
    BRUCK, ME
    SWANK, RT
    GINSBURG, D
    [J]. THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 1006 - 1006
  • [47] von Willebrand disease caused by accelerated clearance of VWF
    Montgomery, R. R.
    Haberichter, S. L.
    [J]. HAEMOPHILIA, 2010, 16 : 84 - 84
  • [48] Circulating von Willebrand factor antigen II in atherosclerosis: a comparison with von Willebrand factor and soluble thrombomodulin
    Blann, AD
    de Romeuf, C
    Mazurier, C
    McCollum, CN
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 1998, 9 (03) : 261 - 266
  • [49] VWF propeptide (VWFpp) demonstrates the relationship between antibody-mediated VWF clearance and VWF production in the phenotypic expression in a case of acquired von Willebrand Syndrome (aVWS)
    Lee, Adrienne
    Sinclair, Gary
    Poon, Man-Chiu
    [J]. HAEMOPHILIA, 2014, 20 : 113 - 114
  • [50] Evidence that von Willebrand factor antigen II interacts with mature platelet and plasma von Willebrand factor
    deRomeuf, C
    Mazurier, C
    [J]. THROMBOSIS AND HAEMOSTASIS, 1997, : P2630 - P2630
12345